Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsDrug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.
Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.
1.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
2.
In cancer survivors, loneliness is associated with a higher risk of death.
3.
How breast tissue density affects your risk of breast cancer
4.
Telemedicine services linked to reducing excess mortality
5.
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
1.
Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System
2.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
3.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
4.
Case Study: Personalized Medicine Based on Genetic Profiling in Oncology
5.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge